Lufenuron
Lufenuron is an insect development inhibitor (IDI) primarily used for the control of flea populations in dogs and cats. It is highly lipophilic and acts systemically after oral or subcutaneous administration. **Key Clinical Points:** - **Flea Control:** Highly effective at breaking the flea life cycle, but **does not kill adult fleas**. It is often combined with adulticides (e.g., nitenpyram, milbemycin) for comprehensive parasite control. - **Lag Period:** Because it only affects eggs and molting larvae, there is a lag period of 60-90 days before the environmental flea population is significantly reduced. - **Alternative Uses:** Historically proposed as an adjunctive treatment for dermatophytosis (fungal infections) and *Encephalitozoon cuniculi* in rabbits, though modern veterinary consensus considers its efficacy for these indications to be highly doubtful. - **Safety:** Exceptionally safe in mammals due to the lack of chitin in mammalian biology.
Mechanism: Lufenuron acts by inhibiting **chitin synthesis, polymerization, and deposition** in insects. - **Mechanism:** It is believed to cause nonspecific inhibition of chitin synthesis related to **serine protease inhibition**. - **Effect on Fleas:** When an adult female flea feeds on a treated animal, she ingests lufenuron. The drug is deposited into her eggs, preventing the development of the exoskeleton and the "egg tooth" needed for hatching. → **Eggs fail to hatch** or larvae die during the molting process. - **Fungal/Parasitic Theory:** The theoretical basis for its use against fungi and *E. cuniculi* is that these organisms also contain chitin in their cell walls, though clinical efficacy has not been proven.
Dosing by species
- Control of flea populations · See the label directions Program and Program with Capstar for using lufenuron with or without nitenpyram · PO · monthly · Cats require a substantially higher oral dosage per kg than dogs for equivalent efficacy. Must be given with a full meal.
- Adjunctive therapy for dermatophytosis · 50-100 mg/kg PO once every 14 days for two treatments, then once a month until at least two negative fungal cultures are obtained · PO · q14d then monthly · Until at least two negative fungal cultures are obtained · Efficacy is considered doubtful by modern standards
- E. cuniculi infections / Flea control · 30 mg/kg PO every month · PO · monthly · Rabbits
- Control of flea populations · See the label directions for Program with Capstar for using lufenuron with nitenpyram · PO · monthly · Must be given with a full meal
- Adjunctive therapy for dermatophytosis · 50-100 mg/kg PO once every 14 days for two treatments, then once a month until at least two negative fungal cultures are obtained · PO · q14d then monthly · Until at least two negative fungal cultures are obtained · Efficacy is considered doubtful by modern standards
Doses are a clinical reference for licensed veterinary professionals. Always confirm against the current label and the individual patient.
Routes of administration
Contraindications
- The cat-labeled injectable product should NOT be used in dogs (severe local reactions are possible)
Adverse effects
- Vomiting
- Lethargy or depression
- Pruritus or urticaria
- Diarrhea
- Dyspnea
- Anorexia
- Reddened skin
- Small lump at injection site (cats receiving injectable formulation)
Monitoring
- Efficacy (reduction in flea population over 60-90 days)
- Fungal cultures (if used for dermatophytosis)
Overdose
Lufenuron has a very wide margin of safety. Growing puppies dosed at levels up to 30X the recommended dose for 10 months showed no overt effects on growth or viability. Cats receiving oral dosages up to 17X the recommended dose were apparently unaffected.
VetSheet drug reference is intended for licensed veterinary professionals as a clinical decision-support aid, not a substitute for professional judgement or the manufacturer’s current label.